ArticleInternational journal of biomaterials2026
Surface Roughness and Color Stability of Conventional Glass Ionomer Cement Reinforced With a Nanofiller Synthesized by the Coprecipitation Method.
Article in International journal of biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Surface Roughness and Color Stability of Conventional Glass Ionomer Cement Reinforced With a Nanofiller Synthesized by the Coprecipitation Method.International journal of biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Modification of conventional glass ionomer cement (GIC) using nanofillers is a promising approach to enhance its clinical performance. This study aimed to evaluate the surface roughness and color stability of conventional GIC after modification with a synthesized 70:30 hydroxyapatite/chitosan (HA/CTS) nanocomposite. Materials and Methods: A 70:30 hydroxyapatite/chitosan nanocomposite was synthesized and incorporated into GIC powder at 1, 3, and 5 wt.%. Four groups were prepared: Group I (control), Group II (1 wt.% HA/CTS), Group III (3 wt.% HA/CTS), and Group IV (5 wt.% HA/CTS). A total of 80 specimens were fabricated ( Results: GIC modified with the 3 wt.% HA/CTS nanocomposite exhibited the lowest surface roughness and demonstrated clinically acceptable color change (ΔE ≤ 3.3) ( Conclusions: Incorporation of the 3 wt.% 70:30 HA/CTS nanocomposite into conventional GIC produced a smoother surface and acceptable esthetic outcome, suggesting a promising formulation for improved clinical performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.